Sunshine Biopharma (SBFM) Competitors $1.48 -0.02 (-1.22%) Closing price 09/15/2025 04:00 PM EasternExtended Trading$1.48 0.00 (0.00%) As of 04:41 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SBFM vs. XCUR, RLYB, NEUP, ENLV, ALVR, NNVC, FBLG, TAOX, PMN, and SONNShould you be buying Sunshine Biopharma stock or one of its competitors? The main competitors of Sunshine Biopharma include Exicure (XCUR), Rallybio (RLYB), Neuphoria Therapeutics (NEUP), Enlivex Therapeutics (ENLV), AlloVir (ALVR), NanoViricides (NNVC), FibroBiologics (FBLG), Synaptogenix (TAOX), Promis Neurosciences (PMN), and Sonnet BioTherapeutics (SONN). These companies are all part of the "pharmaceutical products" industry. Sunshine Biopharma vs. Its Competitors Exicure Rallybio Neuphoria Therapeutics Enlivex Therapeutics AlloVir NanoViricides FibroBiologics Synaptogenix Promis Neurosciences Sonnet BioTherapeutics Sunshine Biopharma (NASDAQ:SBFM) and Exicure (NASDAQ:XCUR) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, media sentiment, dividends and earnings. Which has more risk and volatility, SBFM or XCUR? Sunshine Biopharma has a beta of 1.46, meaning that its stock price is 46% more volatile than the S&P 500. Comparatively, Exicure has a beta of 3.85, meaning that its stock price is 285% more volatile than the S&P 500. Do analysts recommend SBFM or XCUR? Sunshine Biopharma currently has a consensus target price of $15.00, suggesting a potential upside of 913.51%. Given Sunshine Biopharma's stronger consensus rating and higher possible upside, equities analysts plainly believe Sunshine Biopharma is more favorable than Exicure.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sunshine Biopharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Exicure 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders and institutionals have more ownership in SBFM or XCUR? 42.0% of Sunshine Biopharma shares are held by institutional investors. Comparatively, 42.8% of Exicure shares are held by institutional investors. 0.1% of Sunshine Biopharma shares are held by insiders. Comparatively, 8.4% of Exicure shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has preferable valuation & earnings, SBFM or XCUR? Sunshine Biopharma has higher revenue and earnings than Exicure. Exicure is trading at a lower price-to-earnings ratio than Sunshine Biopharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSunshine Biopharma$34.87M0.19-$5.13M-$150.88-0.01Exicure$500K51.44-$9.70M-$3.88-1.05 Does the media refer more to SBFM or XCUR? In the previous week, Sunshine Biopharma and Sunshine Biopharma both had 1 articles in the media. Sunshine Biopharma's average media sentiment score of 1.92 beat Exicure's score of 1.89 indicating that Sunshine Biopharma is being referred to more favorably in the media. Company Overall Sentiment Sunshine Biopharma Very Positive Exicure Very Positive Is SBFM or XCUR more profitable? Exicure has a net margin of 0.00% compared to Sunshine Biopharma's net margin of -17.35%. Sunshine Biopharma's return on equity of -26.04% beat Exicure's return on equity.Company Net Margins Return on Equity Return on Assets Sunshine Biopharma-17.35% -26.04% -20.72% Exicure N/A -192.16%-84.30% SummarySunshine Biopharma beats Exicure on 9 of the 15 factors compared between the two stocks. Get Sunshine Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SBFM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SBFM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SBFM vs. The Competition Export to ExcelMetricSunshine BiopharmaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.83M$3.15B$5.80B$10.16BDividend YieldN/A2.32%5.72%4.60%P/E Ratio-0.0121.2475.1126.39Price / Sales0.19431.67511.76177.24Price / CashN/A44.4425.8129.91Price / Book0.169.6413.456.28Net Income-$5.13M-$53.20M$3.29B$270.38M7 Day Performance4.23%0.07%0.08%1.89%1 Month Performance-0.66%4.27%4.59%6.01%1 Year Performance-47.52%9.62%75.30%25.26% Sunshine Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SBFMSunshine Biopharma2.9186 of 5 stars$1.48-1.2%$15.00+913.5%-47.1%$6.83M$34.87M-0.013Positive NewsXCURExicure1.4571 of 5 stars$4.11-4.5%N/A+154.4%$25.94M$500K-1.0650Positive NewsRLYBRallybio3.2661 of 5 stars$0.59-0.7%$5.00+747.5%-47.5%$24.66M$640K-0.6340Short Interest ↓NEUPNeuphoria Therapeutics2.5873 of 5 stars$13.00+0.1%$21.00+61.5%N/A$24.44M$10K0.00N/AENLVEnlivex Therapeutics2.5487 of 5 stars$1.02-1.9%$10.00+880.4%-32.2%$24.12MN/A-1.7670ALVRAlloVirN/A$4.64+0.4%N/A-77.5%$23.40MN/A-0.23110Gap DownHigh Trading VolumeNNVCNanoViricides0.2144 of 5 stars$1.45+0.3%N/A-9.9%$23.06MN/A-1.9920FBLGFibroBiologics3.4292 of 5 stars$0.54-4.8%$13.00+2,298.5%-83.5%$22.83MN/A-1.5110TAOXSynaptogenix0.0736 of 5 stars$6.38+1.8%N/AN/A$22.27MN/A-0.324PMNPromis Neurosciences3.6701 of 5 stars$0.43-2.5%$4.33+917.2%-66.0%$22.07MN/A-2.035Short Interest ↓Gap DownSONNSonnet BioTherapeutics2.867 of 5 stars$3.23-1.8%$20.00+519.2%-14.6%$22.06M$20K0.0010Positive NewsGap Down Related Companies and Tools Related Companies XCUR Competitors RLYB Competitors NEUP Competitors ENLV Competitors ALVR Competitors NNVC Competitors FBLG Competitors TAOX Competitors PMN Competitors SONN Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SBFM) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sunshine Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sunshine Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
